Cargando…

Immunohistochemical Biomarkers in Gastric Cancer Research and Management

Gastric cancer still represents a major health problem, despite a decrease in its incidence in the last years. Due to the social impact of gastric cancer (GC), there is a need for novel biomarkers in order to stratify patients into appropriate screening, surveillance, or treatment programs. Although...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lastraioli, Elena, Romoli, Maria Raffaella, Arcangeli, Annarosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388584/ https://www.ncbi.nlm.nih.gov/pubmed/22778942 http://dx.doi.org/10.1155/2012/868645

Ejemplares similares

hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers
por: Lastraioli, Elena, et al.
Publicado: (2015)

The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples
por: Lastraioli, Elena, et al.
Publicado: (2019)

Neonatal Nav1.5 Protein Expression in Human Colorectal Cancer: Immunohistochemical Characterization and Clinical Evaluation
por: Lastraioli, Elena, et al.
Publicado: (2021)

A Transcriptomic Approach Reveals Selective Ribosomal Remodelling in the Tumour Versus the Stromal Compartment of Metastatic Colorectal Cancer
por: Lastraioli, Elena, et al.
Publicado: (2021)

K(V)11.1 Potassium Channel and the Na(+)/H(+) Antiporter NHE1 Modulate Adhesion-Dependent Intracellular pH in Colorectal Cancer Cells
por: Iorio, Jessica, et al.
Publicado: (2020)

Corrigendum to “Transcriptomic data of Bevacizumab-adapted colorectal adenocarcinoma cells HCT-116” [Data In Brief, Volume 48, (Available online 17 March 2023) 1-9/Article 109069]
por: Sala, Cesare, et al.
Publicado: (2023)

Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients’ Age and Disease Duration
por: Arcangeli, Adolfo, et al.
Publicado: (2017)

hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients()
por: Iorio, Jessica, et al.
Publicado: (2020)

The Transcriptional Landscape of BRAF Wild Type Metastatic Melanoma: A Pilot Study
por: Lastraioli, Elena, et al.
Publicado: (2022)

New Trends in Cancer Therapy: Targeting Ion Channels and Transporters
por: Arcangeli, Annarosa, et al.
Publicado: (2010)

Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis
por: Duranti, Claudia, et al.
Publicado: (2019)

hERG1 Potassium Channel Expression in Colorectal Adenomas: Comparison with Other Preneoplastic Lesions of the Gastrointestinal Tract
por: Lastraioli, Elena, et al.
Publicado: (2022)

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy
por: Muratori, Leonardo, et al.
Publicado: (2016)

Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses
por: Lottini, Tiziano, et al.
Publicado: (2021)

Evaluation of RAS Mutational Status in Liquid Biopsy to Monitor Disease Progression in Metastatic Colorectal Cancer Patients
por: Lastraioli, Elena, et al.
Publicado: (2023)

CT textural analysis of gastric cancer: correlations with immunohistochemical biomarkers
por: Liu, Shunli, et al.
Publicado: (2018)

Characterization of hERG1 channel role in mouse colorectal carcinogenesis
por: Fiore, Antonella, et al.
Publicado: (2013)

KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation
por: Lastraioli, Elena, et al.
Publicado: (2021)

Circulating miRNome profiling data in Behçet's syndrome
por: Bagni, Giacomo, et al.
Publicado: (2021)

hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer
por: Iorio, Jessica, et al.
Publicado: (2018)

A unique circulating miRNA profile highlights thrombo-inflammation in Behçet’s syndrome
por: Emmi, Giacomo, et al.
Publicado: (2022)

The role of ion channels and transporters in cell proliferation and cancer
por: Becchetti, Andrea, et al.
Publicado: (2013)

hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
por: Crociani, Olivia, et al.
Publicado: (2013)

Significant function and research progress of biomarkers in gastric cancer
por: Ye, Dong Mei, et al.
Publicado: (2020)

A Comment on Ion Channels as Pharmacological Targets in Oncology
por: Becchetti, Andrea, et al.
Publicado: (2008)

Integrins regulate hERG1 dynamics by girdin-dependent Gαi3: signaling and modeling in cancer cells
por: Duranti, Claudia, et al.
Publicado: (2023)

Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
por: Sato, Yasushi, et al.
Publicado: (2023)

Immunohistochemical features and staging of early gastric cancer
por: Gurzu, Simona, et al.
Publicado: (2016)

Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies
por: Utikal, Jochen, et al.
Publicado: (2007)

Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma
por: Lottini, Tiziano, et al.
Publicado: (2023)

Focus on Triple-Negative Breast Cancer: Potassium Channel Expression and Clinical Correlates
por: Lastraioli, Elena
Publicado: (2020)

Immunohistochemical and Physiological Research on Farm Animals
por: Scocco, Paola, et al.
Publicado: (2023)

MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis
por: Wang, Xiao-Tong, et al.
Publicado: (2016)

Immunohistochemical evaluation of biomarkers with predictive role in acromegaly: a literature review
por: Cosma Gliga, Maximilian, et al.
Publicado: (2023)

hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance
por: Lastraioli, Elena, et al.
Publicado: (2016)

Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
por: Birkman, Eva-Maria, et al.
Publicado: (2017)

Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy
por: Cai, Hongzhen, et al.
Publicado: (2022)

Metallothionein – Immunohistochemical Cancer Biomarker: A Meta-Analysis
por: Gumulec, Jaromir, et al.
Publicado: (2014)

Optimal management of resected gastric cancer
por: Giampieri, Riccardo, et al.
Publicado: (2018)

Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures
por: Wang, Xiao-Tong, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_iu4j3rbbd63mrqmov4vv33ofrl